Literature DB >> 2839264

Modification of transplacental distribution of salicylate in rats by acidosis and alkalosis.

D R Varma1.   

Abstract

1. The basis for the existence of a lower concentration of salicylate in the foetal than in the maternal blood was investigated in rats on day 20 of gestation. 2. Bolus injections of sodium salicylate were made into the mother and of [14C]-salicylic acid into its foetuses and serial maternal and foetal blood samples were collected. When derived on the basis of serum salicylic acid uncorrected for differences in ionization in the maternal and foetal blood, the placental clearance was 2.2 fold greater from the foetal to maternal side than that from the maternal to foetal side. 3. The greater foetal placental clearance relative to the maternal placental clearance was not due to any active placental transfer, since there was no evidence of saturation of this process and it was not affected by pretreatment with probenecid. Moreover, salicylic acid was not concentrated by placental slices in vitro and its placental uptake was not affected by dinitrophenol or by cooling. 4. Maternal blood pH was 0.19 units higher than the foetal blood pH. Administration of ammonium chloride or of sodium bicarbonate into the mother increased the foetal to maternal ratio of salicylic acid from 0.6 to approximately 1. 5. It is concluded that a foetal to maternal serum salicylate concentration-ratio of less than 1 simply reflects lower ionization in the foetus than in the mother, because foetal blood pH is lower than the maternal blood pH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839264      PMCID: PMC1853907          DOI: 10.1111/j.1476-5381.1988.tb11488.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Investigation of the maternal to foetal serum concentration gradient of dexamethasone in the rat.

Authors:  D R Varma
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

2.  Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery.

Authors:  G Levy; L K Garrettson
Journal:  Pediatrics       Date:  1974-02       Impact factor: 7.124

3.  Physicochemical factors in maternal-fetal distribution of drugs.

Authors:  R P Maickel; W R Snodgrass
Journal:  Toxicol Appl Pharmacol       Date:  1973-10       Impact factor: 4.219

4.  V. Placental transfer of salicylates under constant maternal blood levels.

Authors:  B M Boulos; C H Almond; L E Davis; M Hammer
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-04

5.  Lack of active transfer of 14C tetraethylammonium and para-aminohippuric acid by the term sheep placenta.

Authors:  J L McNay; E Fuller; T Kishimoto; E Malveaux; P G Dayton
Journal:  Proc Soc Exp Biol Med       Date:  1969-05

Review 6.  Pharmacokinetics in the ovine maternal-fetal unit.

Authors:  H H Szeto
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

7.  Simple and rapid high-pressure liquid chromatographic simultaneous determination of aspirin, salicylic acid, and salicyluric acid in plasma.

Authors:  G W Peng; M A Gadalla; V Smith; A Peng; W L Chiou
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

8.  The placental transfer of acetylsalicylic acid in near-term ewes.

Authors:  D F Anderson; T M Phernetton; J H Rankin
Journal:  Am J Obstet Gynecol       Date:  1980-03-15       Impact factor: 8.661

9.  Seral, uterine and fetal salicylate concentrations after oral administration.

Authors:  M Grönroos; M Haataja; E Honkonen; M Anttila
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1981-09       Impact factor: 2.435

10.  Placental transfer of a substituted pteridine from fetus to mother.

Authors:  J L McNay; P G Dayton
Journal:  Science       Date:  1970-02-13       Impact factor: 47.728

View more
  1 in total

1.  Disposition of orally administered 2,2-Bis(4-hydroxyphenyl)propane (Bisphenol A) in pregnant rats and the placental transfer to fetuses.

Authors:  O Takahashi; S Oishi
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.